Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone in vitro

Beata Derfalvi, Peter Igaz, Kristof A. Fulop, Csaba Szalai, Andras Falus

Research output: Contribution to journalArticle

21 Citations (Scopus)


Growth hormone (GH), given therapeutically in many human diseases, is able to modulate the maturation and function of many cells of immune system. The present study demonstrates the effect of human recombinant GH on the production of acute phase proteins (APP) as well as on the gene expression of jun B proto-oncogene on human hepatoma cell line, HepG2. When applied alone GH resulted in an increase in the transcription of junB proto-oncogene within 30 min. The production of α2-macroglobulin, haptoglobin and fibrinogen was also enhanced by rhGH treatment. However, both IL-6-stimulated junB gene expression (junB mRNA) and biosynthesis of type II APP (α2-macroglobulin, fibrinogen, haptoglobin) were strongly inhibited by the GH. The results indicate that GH has a modulatory role in regulating inflammation both in the absence and presence of IL-6. These findings call for further in vivo studies to determine the potential anti-inflammatory actions of GH therapy. (C) 2000 Academic Press.

Original languageEnglish
Pages (from-to)109-114
Number of pages6
JournalCell biology international
Issue number2
Publication statusPublished - Jan 1 2000



  • Acute phase response
  • Growth hormone
  • IL-6
  • junB

ASJC Scopus subject areas

  • Cell Biology

Cite this